Research - News

A UAB professor has been awarded a $1.25 million grant from the U.S. Department of Education.

The UAB Cancer Center’s Deep South Network now includes community research to better understand local cancer prevention needs.

A UAB study shows a possible risk from low-level exposure to plastic with BPA .
UAB will be part of a new neuroscience research consortium sponsored by the National Institutes of Health.
NIH grant for brain cancer also makes UAB one of few centers with four Specialized Program of Research Excellence awards.
The Office of National AIDS Policy chose UAB as a site to monitor implementation of the National HIV/AIDS Strategy.

A UAB researcher has found a potential new way to treat head and neck cancer.

A UAB sociology professor will make two presentations at an Oxford University symposium.

A UAB pharmacology and toxicology professor has been awarded a grant from the National Institutes of Health.

Daniel L. Smith Jr., Ph.D., instructor in the Department of Nutrition Sciences in the UABSchool of Health Professions, has been selected as one of only two recipients of the 2011 Early-Career Research Grants from the Obesity Society.

The National Institutes of Health awarded a Phase II grant to Yogesh K. Vohra, Ph.D., a professor and University Scholar in UAB’s College of Arts and Sciences, and Vista Engineering for their work on a temporomandibular joint prosthesis.

Several UAB faculty will present papers at this weekend’s American Sociological Association’s 106th annual meeting.

A longer Achilles tendon generates more power, leading to greater energy efficiency and possible performance gains.

A UAB professor says access to computers propels students ahead of those who don’t use them.

UAB creates center for interdisciplinary research and development in computer, accounting and life sciences.

New research from UAB shows definitive link between a protein and cell activation; shutting both down could be a target of new treatments for cancer and autoimmune diseases.

Project has received more than $90 million since 1994 to fund prevention and treatment programs for youth and helped focus resources on minority care.

Less expensive alternative just as safe and effective as common, costly transplant drug.

A drug long used for adults with sickle cell disease could change how the disease is managed in very young children.

Page 61 of 63